| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/27/2004 | WO2001066563A3 T1r taste receptors and genes encoding same |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | WO1999042077A3 Compositions and methods for regulating lymphocyte activation |
| 05/27/2004 | US20040101536 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | CA2813515A1 T cell receptor display |
| 05/27/2004 | CA2757475A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421385A1 Genetic construct intracellular monitoring system |
| 05/26/2004 | EP1421117A2 Compositions and methods for generating chimeric heteromultimers |
| 05/26/2004 | EP1421113A1 Methods of screening based on the egf receptor crystal structure |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP0751781B1 Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1498902A Immune suppression fusion protein, its coded nucleic acid and application |
| 05/21/2004 | WO2004042060A1 Method of immobilising a protein to a zeolite |
| 05/21/2004 | WO2004024925A8 Collectin-complement activating protein chimeras |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | CA2545304A1 Method of immobilising a protein to a zeolite |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040096942 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096822 HCV antigen/antibody combination assay |
| 05/20/2004 | US20040096442 Modified anti-egfr antibodies with reduced immunogenicity |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1037927B1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 05/19/2004 | EP1007551B1 Vaccine against hpv |
| 05/19/2004 | EP0870026B1 Ob protein derivatives having prolonged half-life |
| 05/19/2004 | CN1150327C Producing erythrocyte irritable factor/granulocyte colony irritable factor fusion protein by genetic engineering method |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/18/2004 | US6737062 Immunogenic compositions |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/13/2004 | WO2004040262A2 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/13/2004 | WO2004039846A1 Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2003052050A3 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 05/13/2004 | WO2003014381A9 System for detecting protease |
| 05/13/2004 | WO2003005636A8 Secure header information for multi-content e-mail |
| 05/13/2004 | US20040092711 Hybrid expression of neisserial proteins |
| 05/13/2004 | US20040091895 Human sprouty-4 polypeptide |
| 05/13/2004 | US20040091878 Zinc finger domain recognition code and uses thereof |
| 05/13/2004 | US20040091853 Features a chimeric protein containing beta-lactamase and Vpr/Vpx region; for lentivirus/human immunodeficiency virus (HIV) |
| 05/13/2004 | US20040091498 Defensins: use as antiviral agents |
| 05/13/2004 | US20040091488 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 05/13/2004 | US20040091485 Humanised antibodies to the epidermal growth factor receptor |
| 05/13/2004 | US20040091479 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | CA2503763A1 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/12/2004 | EP1418180A2 Chimeric chains that code for proteins that induce effects directed against viruses |
| 05/12/2004 | EP1417303A2 Kinase crystal structures |
| 05/12/2004 | EP1417237A1 Process for preparation of polypeptides of interest from fusion peolypeptides |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/12/2004 | EP1417231A2 Modified human thymic stromal lymphopoietin |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417221A2 Mimotope of neisseria meningitidis lipooligosaccharide and vaccines containing the same |
| 05/12/2004 | EP1416945A1 Improved heteropolymer complexes and methods for their use |
| 05/12/2004 | CN1495197A G-CSF analogs composition and its preparation method |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/06/2004 | WO2004015113A3 Albumin-fused ciliary neurotrophic factor |
| 05/06/2004 | WO2004001068A3 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 05/06/2004 | WO2003102154A3 Improved receptor detection |
| 05/06/2004 | WO2003099997A3 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/06/2004 | WO2002098456A3 Antigens and vectors for vaccination |
| 05/06/2004 | WO2002087510A3 Subcellular targeting of therapeutic proteins |
| 05/06/2004 | WO2002079387A9 Modular molecular clasps and uses thereof |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040086977 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 05/06/2004 | US20040086976 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 05/06/2004 | US20040086973 Calmodulin-dependent protein kinase inhibitor for treatment and prevention of nervous system disorders |
| 05/06/2004 | US20040086965 Casein peptide fragments with growth-influencing activity on cell cultures |
| 05/06/2004 | US20040086960 Transgenic cell expressing human leukocyte antigen fusion proteins for induction of cytotoxic T cell responses against viral and tumor antigens; immunotherapy |
| 05/06/2004 | US20040086943 Coupling agent containing secordary amide groups |
| 05/06/2004 | US20040086905 Lipid-associated molecules |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086859 Identification of a dual specificity phosphate: dusp-10 |
| 05/06/2004 | US20040086858 Identification of new human gaba transporter |
| 05/06/2004 | US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection |
| 05/06/2004 | US20040086523 Fusion proteins of mycobacterium tuberculosis |
| 05/06/2004 | EP1415998A2 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 05/06/2004 | EP1415145A2 Chimeric protein and its use in electron transfer methods |
| 05/06/2004 | EP1414967A2 Gene associated with leishmania parasite virulence |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0589004B2 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/05/2004 | CN1494589A 方法 Method |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1493597A Separation dendron shaped cell membrane protein gene |
| 05/05/2004 | CN1148577C Antibodies and SCFV immunotoxins specific to improted fire ants, and their application |
| 05/04/2004 | US6730658 Stimulation of lymphatic growth with an FLT4 ligand |
| 05/04/2004 | CA2110442C Process for obtaining proinsulin possessing correctly linked cystine bridges |